Xellarbio is a biotechnology company that focuses on accelerating drug discovery by combining machine learning and Artificial Intelligence with large-scale wet-lab experiments.

Xellarbio

CrUX Dataset

CrUX Top 50m

WordPress 6.6

Co-Founder & CEO

Xin Xie

Business Management

Haiqing Bai

Director of Technology Development

Ming Pan

Scientist II

Alyssa Fanelli

VP of Engineering

Xiaohua Qian

VP, Head of Data Science & AI

Zhiyong Xie

Biotechnology Companies With Fewer Than 1000 Employees (Top 10K)

Greater Boston Area Companies With Fewer Than 1000 Employees (Top 10K)

United States Pharmaceutical Companies (Top 10K)

Greater Boston Area Companies With Fewer Than 50 Employees (Top 10K)

Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.

TriApex

Seed Round - Xellar Biosystems

Newton

Massachusetts

United States

North America

Xellar Biosystems

Xellar Biosystems raises angel+ round and 40 other Greater China deals worth over $431m

Xellar Biosystems on LinkedIn: Xellar Biosystems Joins NVIDIA Inception

India

Asia

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 17, 2024 3:54 AM	d05843d7
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 17, 2024 3:54 AM	753d9e1e
crunchbase trigger	general	Oct 29, 2024 5:10 PM	48042710
crunchbase profile	general	Oct 30, 2024 12:40 PM	5998e48f
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	15c81743
peers	general	Oct 17, 2024 3:54 AM	ce949277
news basic	general	Oct 17, 2024 3:54 AM	fa61c80f
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:XELLARBIO

Xellarbio